Home/Filings/4/0001209191-23-005042
4//SEC Filing

Lanza Frank J 4

Accession 0001209191-23-005042

CIK 0001708493other

Filed

Jan 25, 7:00 PM ET

Accepted

Jan 26, 4:07 PM ET

Size

5.6 KB

Accession

0001209191-23-005042

Insider Transaction Report

Form 4
Period: 2023-01-24
Lanza Frank J
Principal Fin. & Acctng Ofc.
Transactions
  • Award

    Employee Stock Option (right to buy)

    2023-01-24+65,00065,000 total
    Exercise: $0.89Exp: 2033-01-23Common Stock (65,000 underlying)
Footnotes (1)
  • [F1]1/48th of the total stock option will vest and become exercisable monthly on the same day of each month following the vesting commencement date of January 24, 2023, subject to the continuing employment of the Reporting Person on each vesting date.

Issuer

Harpoon Therapeutics, Inc.

CIK 0001708493

Entity typeother

Related Parties

1
  • filerCIK 0001624055

Filing Metadata

Form type
4
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 4:07 PM ET
Size
5.6 KB